Keating Investment Counselors’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.67M Sell
175,168
-4,941
-3% -$268K 2.39% 10
2025
Q4
$8.83M Buy
180,109
+578
+0.3% +$27K 2.45% 7
2025
Q3
$7.75M Sell
179,531
-7,270
-4% -$284K 2.21% 8
2025
Q2
$7.17M Sell
186,801
-2,005
-1% -$76.6K 2.17% 8
2025
Q1
$7.31M Buy
188,806
+25,201
+15% +$923K 2.21% 7
2024
Q4
$5.53M Buy
+163,605
New +$5.89M 1.73% 15
2023
Q1
Sell
-197,918
Closed -$6.95M 82
2022
Q4
$6.95M Buy
197,918
+56,742
+40% +$1.89M 2.72% 14
2022
Q3
$4.16M Buy
141,176
+420
+0.3% +$15.9K 1.86% 19
2022
Q2
$7.66M Sell
140,756
-706
-0.5% -$39K 3.23% 9
2022
Q1
$7.7M Hold
141,462
3.3% 10
2021
Q4
$7.8M Buy
141,462
+106
+0.1% +$5.51K 3.45% 8
2021
Q3
$6.75M Buy
141,356
+1,608
+1% +$80.8K 3.16% 11
2021
Q2
$6.96M Buy
+139,748
New +$6.71M 3.19% 10

Other funds holding GSK